Ipsen在TOXINS 2026分享了有关神经治疗的新数据,推进了对抑郁症等疾病的护理。 Ipsen shared new data on neurological treatments at TOXINS 2026, advancing care for conditions like dystonia.

Ipsen在TOXINS会议上介绍了新的临床数据,突出了神经病治疗方面的进展,并加强了对解决该领域未得到满足的医疗需求的重视。 Ipsen presented new clinical data at the TOXINS conference, highlighting advancements in treatments for neurological conditions and reinforcing its focus on addressing unmet medical needs in this field. 这些发现支持持续努力改善患者的治疗结果,并扩大对诸如 dystonia 和其他运动相关疾病的创新疗法的获取. The findings support ongoing efforts to improve patient outcomes and expand access to innovative therapies for disorders such as dystonia and other movement-related conditions.